1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 20 APRIL 2015

Cancer Drug News 20 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Argos/Lummy Deal Indicative Of Shift Towards Innovation Within Sino-foreign Partnerships
Industry Trend Analysis - Positive Ibrance Data Set Pfizer Further Ahead Although Competition Will Arrive Soon
Industry Brief - Genmab Earns Fifth Milestone In Daratumumab Collaboration with Janssen
Industry Trend Analysis - Expansion Of Copanlisib Programme Highlights Changes Within Bayer And The NHL Market
Industry Brief - FDA Accepts NDA Filing For Bendamustine Rapid Infusion
Industry Brief - Panther Licenses TDZD-8 From University Of Rochester For Leukaemia
Industry Brief - Merck KGaA/Pfizer Initiate Avelumab Phase III Study In Stage IIIb/IV NSCLC
Industry Brief - FDA Grants ODD To AstraZeneca's Tremelimumab For Malignant Mesothelioma
Industry Brief - Opdivo Phase III LC Trial Stopped Early Following Favourable OS Results
Industry Trend Analysis - Keytruda's Impending Approval Will Cause BMS' NSCLC Advantage To Slip
Industry Brief - Health Canada Approves New Indication For Xtandi In MCRPCA
Industry Brief - Active Biotech/Ipsen Discontinue Tasquinimod Development In PCA
Industry Brief - MHRA Approves New Indication For Somatuline Autogel
Industry Brief - 4SC/Menarini Sign Resminostat Licensing Deal In Asia-Pacific
Industry Brief - Transgene/FDA Reach SPA Agreement On Pexa-Vec Phase III Trial
Industry Brief - FDA Grants ODD To Oncolytics' Reolysin For Malignant Glioma
Industry Brief - RXi's Samcyprone Gains FDA ODD For Late-Stage Malignant Melanoma
Industry Brief - Provectus Begins PV-10 Phase III Comparative Trial For Melanoma
Industry Brief - AstraZeneca's Selumetinib Gains FDA ODD For Uveal Melanoma
Industry Brief - TetraLogic/Merck Collaborate On Keytruda/Birinapant Combination Phase I Trial In Solid Tumours
Industry Brief - Ventana/Astellas To Co-Develop Tissue Diagnostics For Targeted Cancer Therapies
Industry Brief - Immunocore/MedImmune Enter Second Collaboration
Industry Brief - US Patent Allowance Granted Covering PV-10 For Cancer
Industry Brief - Sanofi To Apply Innate's Site-Specific Conjugation Technology To Develop ADCs
Industry Trend Analysis - Roche's Pipeline Will Benefit From Genomic Diagnostic Acquisition
Industry Brief - TVM Life Science Ventures VII Invests In Esperas Pharma
Industry Trend Analysis - J&J Oncology Segment Gaining Momentum
Industry Brief - Innocrin Raises Funds To Accelerate VT-464 Development In CRPCA

Table Of Contents

Cancer Drug News 20 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market

  • January 2017
    19 pages
  • Therapy  

    Anticoagulant  

    Cancer  

View report >

Cancer Statistics in Denmark

  • January 2017
    6 pages
  • Therapy  

  • Denmark  

View report >

Hormone and Therapy Market in Pakistan and the US

  • January 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.